US 7829503
Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-fungal agents
granted A61PA61P31/10A61P43/00
Quick answer
US patent 7829503 (Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-fungal agents) held by PTC THERAPEUTICS, INC. expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P31/10, A61P43/00